Tg Therapeutics (TGTX) Depreciation & Amortization (CF) (2011 - 2026)
Tg Therapeutics (TGTX) recorded quarterly Depreciation & Amortization (CF) of $32000.0 in Q1 2026, up 52.38% quarter-over-quarter from $21000.0 in Q4 2025, and up 300.0% on a YoY basis from $8000.0 in Q1 2025.
Tg Therapeutics (TGTX) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Tg Therapeutics' Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $32000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 300.0% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $83000.0 (up 76.6% YoY), while the FY2025 annual figure was $59000.0, down 13.24% from the prior year.
- Depreciation & Amortization (CF) was $32000.0 for Q1 2026 at Tg Therapeutics, up from $21000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $78000.0 in Q2 2022 to a low of $8000.0 in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $39588.2 across 5 years, with a median of $32000.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Depreciation & Amortization (CF) slumped 84.93% in 2024, then jumped 300.0% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $73000.0 in 2022, then sank by 47.95% to $38000.0 in 2023, then slumped by 76.32% to $9000.0 in 2024, then jumped by 133.33% to $21000.0 in 2025, then surged by 52.38% to $32000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $32000.0 (Q1 2026), $21000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Dec 31, 2025 | 21,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Mar 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |